Old Web
English
Sign In
Acemap
>
authorDetail
>
Kenichi Hashimoto
Kenichi Hashimoto
GlaxoSmithKline
Medicine
Internal medicine
Clinical endpoint
Physical therapy
COPD
3
Papers
19
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The IMPACT Study – Single Inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI And UMEC/VI In Patients With COPD: Efficacy And Safety In A Japanese Population
2019
International Journal of Chronic Obstructive Pulmonary Disease
Motokazu Kato
Keisuke Tomii
Kenichi Hashimoto
Yasuko Nezu
Takeo Ishii
C. Elaine Jones
Sally Kilbride
Annette S. Gross
Christine S. Clifton
David A. Lipson
Show All
Source
Cite
Save
Citations (8)
The efficacy and safety of fluticasone/salmeterol compared to fluticasone in children younger than four years of age
2019
Pediatric Allergy and Immunology
Shigemi Yoshihara
Toshikazu Tsubaki
Masanori Ikeda
Warren Lenney
Richard Tomiak
Takako Hattori
Kenichi Hashimoto
Toru Soutome
Shihona Kato
Show All
Source
Cite
Save
Citations (7)
Long-term (52 weeks) safety and tolerability of umeclidinium in Japanese patients with chronic obstructive pulmonary disease.
2016
Current Medical Research and Opinion
Eiji Yamagata
Toru Soutome
Kenichi Hashimoto
Kazuko Mihara
Yuji Tohda
Show All
Source
Cite
Save
Citations (4)
1